Oct 7, 2016 9:19 am EDT Abeona Therapeutics Announces Publication of Preclinical Data Supporting Clinical Translation of Juvenile Batten Disease Gene Therapy
Oct 5, 2016 7:03 am EDT Abeona Therapeutics Announces Data Safety Monitoring Board Approves ABO-102 Dose Escalation for Second Cohort in Phase 1/2 Clinical Trial for Sanfilippo Syndrome Type A
Oct 4, 2016 7:03 am EDT Abeona Therapeutics to Present at Jefferies Gene Editing & Gene Therapy Summit
Sep 26, 2016 7:03 am EDT Abeona Therapeutics Enrolls First Patient in Phase 2 for EB-101 Gene Therapy Clinical Trial for Epidermolysis Bullosa
Sep 23, 2016 7:03 am EDT Abeona Therapeutics to Present at Ladenburg Thalmann 2016 Healthcare Conference
Sep 21, 2016 7:03 am EDT Abeona Therapeutics Announces Licensing of the AIM(TM) Next Generation AAV Gene Therapy Vector Platform From The University of North Carolina at Chapel Hill
Sep 15, 2016 7:03 am EDT Abeona Therapeutics Announces Publication of Preclinical Data Supporting Clinical Translation of MPS IIIA Gene Therapy
Sep 8, 2016 7:03 am EDT Abeona Therapeutics Enrolls 5th Patient in Phase 1/2 Gene Therapy Clinical Trial for Epidermolysis Bullosa
